Latest Insider Transactions at Elevation Oncology, Inc. (ELEV)
This section provides a real-time view of insider transactions for Elevation Oncology, Inc. (ELEV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Elevation Oncology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Elevation Oncology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-6.5%
|
$0
$0.53 P/Share
|
|
Nov 15
2024
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+16.59%
|
-
|
|
Sep 16
2024
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,628
-4.36%
|
$0
$0.61 P/Share
|
|
Sep 16
2024
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,562
+10.58%
|
-
|
|
Aug 15
2024
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
89
-6.86%
|
$0
$0.72 P/Share
|
|
Aug 15
2024
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+18.79%
|
-
|
|
Jun 16
2024
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,628
-4.71%
|
$13,884
$3.23 P/Share
|
|
Jun 16
2024
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,562
+11.34%
|
-
|
|
May 15
2024
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
100
-9.12%
|
$300
$3.73 P/Share
|
|
May 15
2024
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+21.47%
|
-
|
|
Mar 16
2024
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,773
-5.28%
|
$19,092
$4.39 P/Share
|
|
Mar 16
2024
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,562
+12.19%
|
-
|
|
Feb 15
2024
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
403
-33.58%
|
$806
$2.77 P/Share
|
|
Feb 15
2024
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+50.0%
|
-
|
|
Dec 16
2023
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,773
-5.77%
|
$0
$0.51 P/Share
|
|
Dec 16
2023
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,563
+13.19%
|
-
|
|
Sep 16
2023
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,773
-6.37%
|
$0
$0.73 P/Share
|
|
Sep 16
2023
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,562
+14.37%
|
-
|
|
Sep 01
2023
|
Timothy P Clackson |
SELL
Bona fide gift
|
Direct |
15,777
-100.0%
|
-
|
|
Jun 16
2023
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,773
-7.11%
|
$4,773
$1.47 P/Share
|
|
Jun 16
2023
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,563
+15.77%
|
-
|
|
Mar 16
2023
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,773
-8.05%
|
$9,546
$2.35 P/Share
|
|
Mar 16
2023
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,563
+17.48%
|
-
|
|
Dec 16
2022
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,773
-9.27%
|
$0
$0.95 P/Share
|
|
Dec 16
2022
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,562
+19.61%
|
-
|
|
Sep 16
2022
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,773
-10.92%
|
$4,773
$1.25 P/Share
|
|
Sep 16
2022
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,562
+22.32%
|
-
|
|
Jun 16
2022
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
19,095
-38.0%
|
$19,095
$1.26 P/Share
|
|
Jun 16
2022
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,249
+50.0%
|
-
|
|
May 31
2022
|
Timothy P Clackson |
SELL
Bona fide gift
|
Direct |
31,553
-66.67%
|
-
|
|
May 25
2022
|
Ven Bio Global Strategic Fund Iii, L.P. |
SELL
Open market or private sale
|
Direct |
702,737
-26.94%
|
$2,810,948
$4.12 P/Share
|
|
Jun 29
2021
|
Ven Bio Global Strategic Fund Iii, L.P. |
BUY
Open market or private purchase
|
Direct |
625,000
+19.33%
|
$10,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Ven Bio Global Strategic Fund Iii, L.P. |
BUY
Conversion of derivative security
|
Direct |
1,983,167
+50.0%
|
-
|
|
Jun 29
2021
|
Aisling Capital Iv, LP |
BUY
Open market or private purchase
|
Direct |
187,500
+6.2%
|
$3,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Aisling Capital Iv, LP |
BUY
Conversion of derivative security
|
Direct |
2,351,592
+30.57%
|
-
|
|
Jun 29
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
312,500
+11.65%
|
$5,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,057,642
+33.16%
|
-
|
|
Jun 29
2021
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
250,000
+10.07%
|
$4,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
1,983,168
+50.0%
|
-
|
|
Jun 29
2021
|
Vertex Global Hc Fund Ii Pte. Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+9.77%
|
$4,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Vertex Global Hc Fund Ii Pte. Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,057,642
+33.16%
|
-
|